Product Information

DOFETILIDE 125 MCG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.1979 per EA under NDC 00904752208. Its NADAC has been published 90 times since Feb 26, 2025.

FDA first approved this application on Jun 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Dofetilide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DOFETILIDE 125 MCG CAPSULE

Dofetilide
$0.1979per EA
High Outlier

Strength

.125 mg/1

NDC

00904752208

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DOFETILIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207058

FDA Approved

6/6/2016

TE Code

AB

On Market Since

10/17/2024

Pharmacological Classes

Price Statistics

The NADAC for DOFETILIDE 125 MCG CAPSULE has been published 90 times since Feb 26, 2025, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1979 per EA
All-time high$0.2425 (Apr 16, 2025)
All-time low$0.1925 (Feb 18, 2026)
52-week high$0.2113
52-week low$0.1925
Median price$0.2046
Average price$0.2092
Largest weekly change-8.6% (May 21, 2025)
Weeks tracked90
Tracking sinceFeb 26, 2025

Price History

1W

0.0%

1M

-2.3%

3M

-0.9%

6M

-3.3%

1Y

-10.0%

3Y

N/A

5Y

N/A

All

-12.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOFETILIDE 125 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 125 MCG CAPSULE, manufactured by Major Pharmaceuticals, is $0.1979 per EA (NDC 00904752208), effective Nov 11, 2026.

How has the price of DOFETILIDE 125 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOFETILIDE 125 MCG CAPSULE has declined 12.1%. It has been tracked across 90 weekly CMS publications since Feb 26, 2025.

What are the highest and lowest recorded NADAC prices for DOFETILIDE 125 MCG CAPSULE?

Since Feb 26, 2025, the NADAC for DOFETILIDE 125 MCG CAPSULE has ranged from a low of $0.1925 (Feb 18, 2026) to a high of $0.2425 (Apr 16, 2025), with a median of $0.2046 per EA.

Are there cheaper alternatives to DOFETILIDE 125 MCG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOFETILIDE 125 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOFETILIDE 125 MCG CAPSULE?

DOFETILIDE 125 MCG CAPSULE (NDC 00904752208) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.